American Registry of Ambulatory or Acutely Decompensated Heart Failure

NCT05295641 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6732

Last updated 2025-04-13

No results posted yet for this study

Summary

The purpose of this study is to better characterize and understand the population of patients with ambulatory or acutely decompensated heart failure in the American continent, getting to know their sociodemographic, clinical and paraclinical characteristics

Conditions

Sponsors & Collaborators

  • Sociedad Interamericana de Cardiología (SIAC)

    collaborator UNKNOWN
  • Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH)

    collaborator UNKNOWN
  • Fundacion Clinica Valle del Lili

    lead OTHER

Principal Investigators

  • Juan E Gomez-Mesa, MD · Fundacion Clinica Valle del Lili

  • Mario Speranza, MD · Hospital Clínica Bíblica

  • Eduardo R. Perna, MD · Instituto De Cardiología J. F. Cabral

  • Víctor A. Rossel, MD · Instituto Nacional del Tórax

  • Daniel Quesada, MD · Hospital San Vicente de Paul

  • Mark H. Drazner, MD · University of Texas Southwestern Medical Center

  • Alexander Romero, MD · Hospital Santo Tomas

  • Walter Alarco, MD · Instituto Nacional Cardiovascular INCOR

  • Sebastian Seni-Molina, MD · Fundación Valle del Lili - Registry Coordinator

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • United States
  • Argentina
  • Bolivia
  • Chile
  • Colombia
  • Costa Rica
  • Cuba
  • Dominican Republic
  • Ecuador
  • El Salvador
  • Guatemala
  • Honduras
  • Jamaica
  • Mexico
  • Nicaragua
  • Panama
  • Paraguay
  • Peru
  • Suriname
  • Uruguay
  • Venezuela

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05295641 on ClinicalTrials.gov